ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
H

Low-intensity TKI-based Therapy for Ph+ ALL

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Hervé Dombret
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Hervé Dombret
0 views
November 8, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Symposium on Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
19:21
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Low-intensity TKI-based Therapy for Ph+ ALL

Feat. H. Dombret
22:07
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

How to Identify and Manage Ph-like ALL

Feat. S. Tasian
23:27
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Stem Cell Transplant for Ph+ ALL: Who, When, How

Feat. F. Lussana
21:00
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Ph+ ALL - TKI-based Chemotherapy

Feat. E. Jabbour
18:52
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

New Approaches for Ph+ ALL (Monoclonal Antibodies, CART cells New TK…

Feat. G. Martinelli